S&P 500 7,443 -0.96% Nasdaq 25,508 -1.41% Dow Jones 51,839 -1.26% FTSE 100 10,525 +0.25% DAX 24,847 -1.07% Nikkei 225 66,068 -2.47% Hang Seng 25,147 +3.31% WTI Crude 82.02 +3.89% Gold 4,077 +2.29% US 10-Year Treasury Yield 4.598 +0.28% S&P 500 7,443 -0.96% Nasdaq 25,508 -1.41% Dow Jones 51,839 -1.26% FTSE 100 10,525 +0.25% DAX 24,847 -1.07% Nikkei 225 66,068 -2.47% Hang Seng 25,147 +3.31% WTI Crude 82.02 +3.89% Gold 4,077 +2.29% US 10-Year Treasury Yield 4.598 +0.28%

LATEST

10 Major companies the EFCC is prosecuting in 2026●Burnham cuts VAT on household electricity bills; UK borrows less than expected in June – business live●DMO records N1.74 trillion demand, allots N929.3 billion across FGN bonds●Samsung Electronics shares rise as robotics move highlights push into physical AI●Upcoming IPO: Xtranet Technologies IPO to hit Dalal Street on 23 July. GMP hints 20% listing pop. Should you buy?●Foreign investors sell Nifty Bank futures on margin worries●SBI Funds Management share price extends gains after decent listing. Should you buy, sell or hold the stock?●MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusions●10 Major companies the EFCC is prosecuting in 2026●Burnham cuts VAT on household electricity bills; UK borrows less than expected in June – business live●DMO records N1.74 trillion demand, allots N929.3 billion across FGN bonds●Samsung Electronics shares rise as robotics move highlights push into physical AI●Upcoming IPO: Xtranet Technologies IPO to hit Dalal Street on 23 July. GMP hints 20% listing pop. Should you buy?●Foreign investors sell Nifty Bank futures on margin worries●SBI Funds Management share price extends gains after decent listing. Should you buy, sell or hold the stock?●MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusions●

Front Page

The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame

US Top News and Analysis · 12h ago

The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame

The FDA's investigation into the source of the cyclosporiasis outbreak is causing confusion as companies and consumers alike navigate new updates.

Read the full story at US Top News and Analysis →

More Front Page

Samsung forms RX robotics unit, shares surge on $40.7B AI pivot

EUROS · 14m ago

UK military ‘eyes innovative electric flying taxi’ as 2029 launch planned

Business | The Guardian · 44m ago

British Gas mixed up our energy meter – but now I’m being penalised

Business | The Guardian · 44m ago

Burnham announces plans to cut VAT on electricity bills as first cost-of-living move

Business | The Guardian · 1h ago